EUVIMEDEUVIMED entdecken
Open Access

The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma

Junjie Bai, Xiaoyan Li, Yahui Wen, Qing Lu, Ru Chen, Rong Liu, Tong Shangguan, Yushi Ye, Jun Lin, Weizhong Cai, Deyong Kang, Jianhui Chen

Aging · 2024

DOI: 10.18632/aging.205549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Junjie Bai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Leiomyomatosis, Uterine Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsLeiomyomatosisUterine NeoplasmsSkin NeoplasmsHumansFemaleFumarate HydrataseRetrospective StudiesVascular Endothelial Growth Factor ATreatment Outcome

Stichwörter der Autor:innen

fumarate hydratasehereditary leiomyomatosis and renal cell carcinomaimmunohistochemistrymolecularpapillaryrenal cell carcinoma

Substanzen

Fumarate HydrataseVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Urology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian, P.R. China.
  • The Graduate School of Fujian Medical University, Fuzhou 350000, Fujian, P.R. China.
  • Department of Pathology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian, P.R. China.
  • Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian, P.R. China.
  • Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian, P.R. China.

Zitieren

APA

Bai, J., Li, X., Wen, Y., Lu, Q., Chen, R., Liu, R., Shangguan, T., Ye, Y., Lin, J., Cai, W., Kang, D., & Chen, J. (2024). The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma. Aging. https://doi.org/10.18632/aging.205549

Vancouver

Bai J, Li X, Wen Y, Lu Q, Chen R, Liu R, et al. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma. Aging. 2024. doi:10.18632/aging.205549

BibTeX
@article{Bai2024,
  author = {Bai, Junjie and Li, Xiaoyan and Wen, Yahui and Lu, Qing and Chen, Ru and Liu, Rong and Shangguan, Tong and Ye, Yushi and Lin, Jun and Cai, Weizhong and Kang, Deyong and Chen, Jianhui},
  title = {The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205549}
}
Kostenlos starten →